Anthropic one of the biggest AI companies has reportedly chosen to list its on the Nasdaq — a major new AI stock coming to market. Meanwhile Goldman says AI is behind half of all big-company profit growth and suppliers like Foxconn keep confirming demand

Verdict: Watch-list, not a buy — wait for the RSI reversal to confirm

The thesis has real support — Nasdaq grew revenue 11.6% to $8.26B with $2.0B free cash flow and a 14.6% return on equity, and Goldman earned $17.2B net income on a 13.7% return on equity, so you are buying profitable franchises, not story stocks. But the strongest point against is what insiders did: per the ownership filings covering the period ended June 30, 2026, Goldman insiders were net open-market sellers of about $29.3M, C3.ai about $8.0M, and Nasdaq about $1.4M — a bearish overlay on the very names the thesis champions. C3.ai, the pure-play AI leg, remains in bad shape with full-year revenue down 35.7% to $250.3M, a -188% net margin, and -$192.1M in free cash flow, even as its quarterly margins improved (net margin narrowed 26 points to -224%, gross margin up 4.6 points to 21.9%). Nothing is buyable today: GS and NDAQ sit deeply oversold with RSI near 20, still roughly 24.6 and 25.5 points away from the 45-cross that completes entry, while AI at RSI 50.5 fails the sub-40 prerequisite; no robust parameter setup was established, so the levels are as written. A confirmed Anthropic Nasdaq listing timeline is the single fact that would most strengthen the fundamental case against that insider-selling headwind.

Trade now: no entry yet — two of three legs are close, none is live

Nothing to buy today. This is a three-leg watch-list setup on NDAQ, GS and AI, each waiting on the same sequence: price below the 50-day moving average and the lower Bollinger band, RSI (14) below 40, then RSI crossing back above 45. No leg currently shows the full combination — exactly what the strategy is designed to wait for. This is a watch-list state, not a trust problem. The closest legs are GS and NDAQ. GS closed at $937.98 with RSI at 20.4, already below both its 50-day average ($1,025.65) and its lower Bollinger band ($1,020.33), so three of the four conditions are met; the only missing piece is RSI recovering through 45, currently 24.6 points away. NDAQ closed at $88.76 with RSI at 19.5, likewise under its average ($93.56) and band ($95.86), waiting on the same RSI recovery from 25.5 points away. AI, at $10.56, is furthest along on price but earliest on momentum: its RSI is 50.5, still 5.5 points above the 45-cross and 10.5 points above the sub-40 requirement. If an entry does trigger, the position rules are mechanical: the stop is a 2.4% loss from entry (or a break of the second-ranked support), the take-profit is 4.8% (or the first resistance level), and an RSI reading above 70 would also close the trade. That produces a fixed 2-to-1 reward-to-risk per leg, with positions capped at 25% of the book. "Wait" here means something concrete: no orders until RSI first drops below 40 and then crosses back above 45 on the daily bar. For GS and NDAQ, the next several sessions will decide whether the reversal arm completes. A note on tuning: the research author did request a bounded optimization to test whether the thresholds above are too strict, but the sensitivity run exceeded its time budget, so no robust parameter adjustment was established. The levels shown are the strategy as written.

The Demand Story Is Real — and the Cash Isn't ALL Going Up in Smoke

The bull case rests on a macro claim — per the idea, Goldman has said AI is driving roughly half of all large-company profit growth, and supplier confirmations like Foxconn's keep demand grounded in physical orders rather than hype. If that profit migration is real, the exchange that lists the next wave of AI debuts benefits directly. The idea's own thesis argues that Anthropic reportedly choosing Nasdaq for its listing is exactly the kind of franchise event that validates this: a major AI company coming to market through the NDAQ rail is a demand signal that compounds into recurring listing, data, and trading revenue rather than a one-off fee. The tracked holdings back parts of this with hard numbers. Nasdaq grew full-year revenue 11.6% year over year to $8.26B, produced $2.0B in free cash flow (top 3% of its financials peer group), and returned a 14.6% return on equity. Goldman Sachs, the entity whose own research underpins the demand narrative, posted $17.2B in net income on a 13.7% return on equity for its fiscal year — a business positioned to monetize the AI listing wave through underwriting and trading. These are not story stocks; they are profitable franchises sitting on top of the theme. The entry rules were evaluated on real daily bars but never fired in the evaluated window — across roughly 1,236 bars over the past five years for the NDAQ pair, the conditions never aligned, so this is a watch-list setup rather than an active signal. That is not a trust deficit; it simply means the strategy is waiting for a pullback-and-recovery state (price below the 50-day trend and lower band, momentum dipping under 40 then reclaiming 45) that has historically offered better entries than chasing strength. The asymmetry the thesis is really trading: you are long listed-market infrastructure and the AI monetizers, sized with a hard 2.4% risk stop and a 4.8% profit target, while the Nasdaq listing pipeline provides the catalyst. Whether C3.ai's improving trajectory — net margin narrowed by 26 percentage points quarter over quarter to -224%, and gross margin jumped 4.6 points to 21.9% in its fiscal Q4 — marks the start of a genuine turnaround is the open question the position sizing is built to survive.

Insiders Are Selling the Theme the Thesis Is Buying

The most uncomfortable number in this idea is insider behavior. As of the June 30, 2026 filing period, Goldman Sachs insiders…

Scores

• Conviction score breakdown: 44
• Thesis support: 55
• Trade readiness: 40
• Risk quality: 50
• Trigger proximity: 20
• Fundamentals trend: 55

Watch items

• GS — RSI (14)
• NDAQ — RSI (14)
• AI — RSI (14)
• AI — Price vs 50-day EMA
• GS — Insider net open-market selling
• NDAQ — Next ex-dividend date